Journal
DIGESTIVE AND LIVER DISEASE
Volume 44, Issue 3, Pages 245-250Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2011.10.022
Keywords
Chronic hepatitis C infection; Lipid metabolism; Non-alcoholic fatty liver disease; Oxidative stress
Categories
Funding
- MIUR
- Progetti di Ateneo, University of L'Aquila
- Fondazione A. Cesalpino
Ask authors/readers for more resources
Background: Hepatitis C virus infection is characterised by enhanced oxidative stress, which can be measured quantitatively by plasma oxysterol concentration. These molecules may affect lipid metabolism through the activation of Liver X Receptors. Hepatitis C virus exploits host lipid metabolism to facilitate its replication and diffusion. In our study we aimed to evaluate and highlight the potential pathogenetic role of oxysterols, 7-ketocholesterol and 7-beta-hydroxycholesterol, in hepatitis C virus-related lipid dysmetabolism. Methods: The study was performed in 42 patients with chronic hepatitis C (93% genotype 1b) and 38 nonalcoholic fatty liver disease patients. Plasma oxysterols 7-ketocholesterol and 7-beta-hydroxycholesterol were determined by isotope dilution gas chromatography/mass spectrometry. Results: Gas chromatography/mass spectrometry revealed higher 7-ketocholesterol (71.2 +/- 77.3 vs 30.4 +/- 14.5; p < 0.005) and 7-beta-hydroxycholesterol (23.7 +/- 20.6 vs 11.5 +/- 4.9; p < 0.001) plasma levels in hepatitis C virus patients. Furthermore, multivariate regression analysis highlighted an inverse independent correlation between high oxysterol levels and low low-density lipoprotein cholesterol (p = 0.01 for 7-beta-hydroxycholesterol; p = 0.02 for 7-ketocholesterol) in the hepatitis C virus group; in contrast, the nonalcoholic fatty liver disease group showed a direct correlation between oxysterol levels and low-density lipoprotein-cholesterol (p < 0.001 for 7-beta-hydroxycholesterol; p = 0.002 for 7-ketocholesterol). Conclusion: These different correlations reveal profound differences in lipid dysmetabolism between chronic hepatitis C and non-alcoholic fatty liver disease patients. (C) 2011 Editrice Gastroenterologica Italians S.r.l. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available